APA
Tsuchiya C. T., Kim H. S. J., Maximo M. F. M. & Ramos L. A. (20160610). Cost-Minimization Analysis of Bevacizumab Verse Cetuximab in First-Line Treatment for Metastatic Colorectal Cancer in Kras Wild-Type Patients in the Supplementary Health Care System in Brazil. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
Chicago
Tsuchiya C T, Kim H S J, Maximo M F M and Ramos L A. 20160610. Cost-Minimization Analysis of Bevacizumab Verse Cetuximab in First-Line Treatment for Metastatic Colorectal Cancer in Kras Wild-Type Patients in the Supplementary Health Care System in Brazil. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
Harvard
Tsuchiya C. T., Kim H. S. J., Maximo M. F. M. and Ramos L. A. (20160610). Cost-Minimization Analysis of Bevacizumab Verse Cetuximab in First-Line Treatment for Metastatic Colorectal Cancer in Kras Wild-Type Patients in the Supplementary Health Care System in Brazil. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
MLA
Tsuchiya C T, Kim H S J, Maximo M F M and Ramos L A. Cost-Minimization Analysis of Bevacizumab Verse Cetuximab in First-Line Treatment for Metastatic Colorectal Cancer in Kras Wild-Type Patients in the Supplementary Health Care System in Brazil. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 20160610.